A Long-term Follow-up Study of Patients Who Received MB-105

March Biosciences Inc

Status: Begins enrollment this month

Conditions: Any Patient Treated With MB-105

Treatments: Biological: MB-105

Study type: Observational

Funder types: Industry

Identifiers

NCT07340814

MB-105-202

Details and patient eligibility

About

This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study

Full description

This study is for long term follow up of efficacy and safety for any patient treated with MB-105 who has consented to joining the LTFU study. There are no exclusion criteria.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Received MB-105 Signed informed consent Agree to transfer of samples from previous study Able to comply with study requirements

Exclusion criteria

N/A

Trial design

40 participants in 1 patient group

Open Observation

Description:

All patients who previously received MB-105 on another study

Treatment:

Biological: MB-105